Cyclosporine Treats Severe Poison Ivy in Case Study

JUNE 11, 2014
In a case study presented at the American Academy of Allergy Asthma and Immunology Annual Meeting, researchers successfully treated a 33-year-old patient with yearly, unavoidable poision ivy exposure without using steroids.

Instead, researchers used a 200-mg/day cyclosporine regimen during the patient's exposure period, which resulted in a resolution of poison ivy symptoms after 6 weeks of therapy. The dose was also decreased to 100 mg every other day without the poison ivy symptoms returning, and without the need for topical or systemic corticosteroids.

SHARE THIS SHARE THIS
0
 

In Seniors: Consider CMV Serostatus
When Recommending Flu Vaccine

Older people who have cytomegalovirus seem to have less robust responses to the trivalent influenza vaccine than those who do not have CMV.


 

 

Conference Coverage
News from the year's biggest meetings


Pharmacist Education
Clinical features with downloadable PDFs


 

SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.